Relx plc (REL)

Sector:

IT Services

Index:

FTSE 100

3,540.00p
   
  • Change Today:
      90.00p
  • 52 Week High: 4,135.00p
  • 52 Week Low: 3,337.00p
  • Currency: UK Pounds
  • Shares Issued: 1,830.04m
  • Volume: 7,292,661
  • Market Cap: £64,783m
  • RiskGrade: 128

Relx confirms guidance after 'strong' start to the year

By Abigail Townsend

Date: Thursday 24 Apr 2025

LONDON (ShareCast) - (Sharecast News) - Relx reiterated its full-year outlook on Thursday, after the analytics provider said the year had got off to a "strong" start.
The global firm, which provides information-based analytics and decision tools to professionals businesses, said underlying revenues had grown in all four of its divisions.

In risk, which accounts for 34% of group sales, strong revenue growth had been driven largely by financial crime compliance and by digital fraud and identity.

In its scientific, technical and medical unit, Relx's second-biggest division, the jump in revenues was attributed to "the evolution of the business mix".

Relx said: "The full-year outlook is unchanged.

"We continue to see positive momentum across the group, and we expect another year of strong underlying growth in revenue and adjusted operating profit, as well as strong growth in adjusted earnings per share on a constant currency basis."

As at 0830 BST, the blue chip's London-listed shares were up 1% at 3,965p. The company, which employs around 36,000 people across more than 180 countries, is also listed in Amsterdam and New York.

Relx, formerly known as Reed Elsevier, was updating investors ahead of its annual general meeting. Its year end is 31 December 2025.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Reed Elsevier Market Data

Currency UK Pounds
Share Price 3,540.00p
Change Today 90.00p
% Change 2.61 %
52 Week High 4,135.00p
52 Week Low 3,337.00p
Volume 7,292,661
Shares Issued 1,830.04m
Market Cap £64,783m
RiskGrade 128

Reed Elsevier Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.99% below the market average98.99% below the market average98.99% below the market average98.99% below the market average98.99% below the market average
87.01% below the sector average87.01% below the sector average87.01% below the sector average87.01% below the sector average87.01% below the sector average
Price Trend
20.82% above the market average20.82% above the market average20.82% above the market average20.82% above the market average20.82% above the market average
58.02% above the sector average58.02% above the sector average58.02% above the sector average58.02% above the sector average58.02% above the sector average
Income
90.22% below the market average90.22% below the market average90.22% below the market average90.22% below the market average90.22% below the market average
53.85% below the sector average53.85% below the sector average53.85% below the sector average53.85% below the sector average53.85% below the sector average
Growth
16.80% above the market average16.80% above the market average16.80% above the market average16.80% above the market average16.80% above the market average
22.67% below the sector average22.67% below the sector average22.67% below the sector average22.67% below the sector average22.67% below the sector average

What The Brokers Say

Strong Buy 4
Buy 6
Neutral 5
Sell 0
Strong Sell 0
Total 15
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Reed Elsevier Dividends

  Latest Previous
  Interim Final
Ex-Div 07-Aug-25 08-May-25
Paid 11-Sep-25 19-Jun-25
Amount 19.50p 44.80p

Trades for 18-Sep-2025

Time Volume / Share Price
17:09 7,100 @ 3,530.13p
10:06 401,323 @ 3,520.00p
16:48 1,553 @ 3,540.00p
16:36 208,922 @ 3,553.75p
16:35 4,072 @ 3,540.00p

Reed Elsevier Key Personnel

CEO Erik Engstrom
CFO N L Luff
Chair Paul Walker

Top of Page